Heinemann V, Stintzing S, Kirchner T, Boeck S, Jung A. Clinical relevance of EGFR-and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR. Cancer Treat Rev 2009;35:262–71.Web of ScienceCrossrefGoogle Scholar
Morgan SR, Whiteley J, Donald E, Smith J, Eisenberg MT, Kallam E, et al. Comparison of KRAS mutation assessment in tumor DNA and circulating free DNA in plasma and serum samples. Clin Med Insights Pathol 2012;5:15–22.PubMedGoogle Scholar
Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012;366:883–92.CrossrefPubMedWeb of ScienceGoogle Scholar
Chen KZ, Lou F, Yang F, Zhang JB, Ye H, Chen W, et al. Circulating tumor DNA detection in early-stage non-small cell lung cancer patients by targeted sequencing. Sci Rep 2016;6:31985.CrossrefPubMedWeb of ScienceGoogle Scholar
Ma F, Zhu W, Guan Y, Yang L, Xia X, Chen S, et al. ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy. Oncotarget 2016;7:66020–31.PubMedWeb of ScienceGoogle Scholar
Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, et al. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin Cancer Res 2007;13:7296–304.PubMedCrossrefWeb of ScienceGoogle Scholar
Thierry AR, El Messaoudi S, Gahan PB, Anker P, Stroun M. Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev 2016;35:347–76.Web of SciencePubMedCrossrefGoogle Scholar
Peeters M, Price T, Van Laethem J-L. Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today? Oncologist 2009;14:29–39.Web of ScienceCrossrefPubMedGoogle Scholar
Karlovich C, Goldman JW, Sun JM, Mann E, Sequist LV, Konopa K, et al. Assessment of EGFR mutation status in matched plasma and tumor tissue of NSCLC patients from a phase I study of rociletinib (CO-1686). Clin Cancer Res 2016;22:2386–95.Web of SciencePubMedCrossrefGoogle Scholar
Thress KS, Brant R, Carr TH, Dearden S, Jenkins S, Brown H, et al. EGFR mutation detection in ctDNA from NSCLC patient plasma: a cross-platform comparison of leading technologies to support the clinical development of AZD9291. Lung Cancer 2015;90:509–15.PubMedCrossrefWeb of ScienceGoogle Scholar
Joung JG, Bae JS, Kim SC, Jung H, Park WY, Song SY. Genomic characterization and comparison of multi-regional and pooled tumor biopsy specimens. PLoS One 2016;11:e0152574.PubMedWeb of ScienceCrossrefGoogle Scholar
Yeo T, Tan SJ, Lim CL, Lau DP, Chua YW, Krisna SS, et al. Microfluidic enrichment for the single cell analysis of circulating tumor cells. Sci Rep 2016;6:22076.PubMedCrossrefWeb of ScienceGoogle Scholar
About the article
Published Online: 2018-07-17
Published in Print: 2018-12-19
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This work was supported by a research grant provided by Xiangyang No. 1 People’s Hospital.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.